Company Analysis

Cellectis S.A. (CLLS)

Nasdaq: CLLS · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2014
Grade5.6
◀ Past 4.9● Present 5.4▶ Future 6.7
2 est.

Who runs Cellectis S.A.

The record holds no Form 3, 4 or 5 for this company yet, so no officer or director is named.
SI Assistanton CLLS · research, not advice